Basim M. Khashman1, Suhad K. Karim2, Hanady Mohammed Alhilli3 and Muna J. Ali1
1National Cancer Research Center, University of Baghdad, Iraq.
2Department of Scientific Affairs, Presidency of the University of Baghdad, University of Baghdad, Iraq.
3Puplic Health Department, Infectious Diseases control Unit, University of Health, Alkarkh Health Directorate Baghdad, Iraq.
The cervical cancer considered as the fourth female prevalent disease worldwide it was once the most extensively recognized female cancer two in many lowincome countries (Ferlay et al, 2012). Comparing with other cancers; screening for cervical cancer is the most valuable especially for detecting cervical pre-cancerous lesions by using Pap smear technique, which is also used for detection of high-risk types of HPV that are the causative agent of 70% cervical tumors (WHO, 2012; Nwabichie and Rosliza, 2017)